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Abstract
Background: Video-assisted thoracoscopic surgery (VATS) has an important role in management of pleural empyema. The
objective of this study was to assess the predictors for conversion from VATS to open thoracotomy in an assumed stage II post-
pneumonic empyema.
Methods: This prospective randomized study included 120 patients admitted to cardio-thoracic surgery department, Benha Uni-
versity, between 2011 and 2016. All cases were enrolled for thoracoscopic debridement for an assumed stage II postpneumonic
empyema. If stage III empyema was diagnosed during thoracoscopy, conversion to thoracotomy became indicated. Predictors for
conversion to thoracotomy were assessed in a univariate, a bivariate correlation and a multivariate analysis using several variables
like age, sex, associated comorbidities, duration of symptoms, pleural fluid analysis, and pleural thickness measured by CT scan.
Results: Out of 120 patients, thoracoscopic management was successful in 82 (68%) patients, while conversion to thoracotomy was
done in 38 (32%) patients. Conversion to thoracotomy was higher in patients with long duration of symptoms (p < 0.001) with
cutoff value at 18.1 days, increased pleural thickness (p < 0.001) with cutoff value at 3.95 mm, increased LDH with cutoff value at
1854 IU/L, and Gram-negative infection of pleural fluid (p < 0.001). Multivariate analysis identified that the duration of symptoms,
gram-negative bacteria, LDH and pleural thickness were the significant predictors for conversion from VATS to thoracotomy.
Conclusion: Predictive factors for conversion to thoracotomy in an assumed stage II postpneumonic empyema include long
duration, Gram-negative bacterial infection, increased LDH, and increased pleural thickness.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Parapneumonic effusion is a pleural fluid accumulation in the presence of pulmonary infection. 10e20% of cases
with parapneumonic effusion develop complicated parapneumonic effusion or postpneumonic empyema [1]. Post-
pneumonic empyema has high morbidity in spite of its low incidence because of the effective antibiotic management* Corresponding author.
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vention of recurrent infection and subsequent restrictions. Inadequate drainage of this empyema with persistent signs
of infection is the indication for surgery. Any delay in this surgical management will increase the morbidity and
mortality [3].
Guidelines for management of empyema depend upon the stage of empyema. During stage I empyema, there is
an exudative fluid without any encystations which usually responds to antibiotics and thoracocentesis or chest tube
drainage. The fibrinopurulent phase or stage II disease is characterized by turbid or frankly purulent pleural fluid
associated with fibrin deposits over visceral and parietal pleurae. CT scan findings include pleural enhancement and
encysted effusion without any restriction. Stage II empyema can be managed by fibrinolytic therapy or video-
assisted thoracoscopic debridement. In stage III empyema, there is an increased thickness of pleura with signs of
restriction on CT scan. Freeing the trapped lung with prevention of recurrence or late restriction can be achieved by
decortication [3].
Recently, VATS pleural adhesiolysis and decortication have also been proven to serve as an effective treatment
modality in the early stages of empyema, especially during the fibrinopurulent stage [4e6]. Although still in debate,
many authors have reported that the effectiveness of VATS drainage and decortication is at least equivalent to that of
open decortication in terms of resolution, even in the advanced stages of empyema [7e10]. New technical advances in
endoscopic instruments have increased the role of VATS inmanagement of many thoracic surgical diseases which were
previously treated by thoracotomy only [11,12]. Choosing the best surgical approach is a confusing clinical problem
due to lack of specific clinical, radiological and laboratory indicators for a precise preoperative staging of empyema [3].
2. Patients and methods
This prospective study included 120 patients admitted to cardiothoracic surgery department, Benha University,
between 2011 and 2016. All patients were informed that a VATS approach will be attempted and informed consent
was obtained to proceed to thoracotomy if a stage III empyema was found at exploration by VATS. Samples of pleural
fluid were collected for biochemical, cytological and bacteriological examination. The predictors for conversion from
VATS to open thoracotomy in an assumed stage II postpneumonic empyema were evaluated.
2.1. Patient selection
According to the American Thoracic Society, patients with assumed stage II empyema and history of recent
pneumonia (postpneumonic empyema) were enrolled in this study. Enrollment criteria consisted of the presence of
encysted pleural effusion with pleural enhancement on CT scan in addition to the presence of signs of infection,
weight loss and chest pain. Pleural fluid was examined after either thoracocentesis or chest tube drainage. Any item of
the following criteria [13,14] was applied for the diagnosis of thoracic empyema:
1. Frank pus obtained by thoracocentesis.
2. Presence of bacteria detected by Gram stain or by culture.
3. Or pleural fluid analysis with all of the following: pH below 7.2, glucose level less than 40 mg/dl, LDH above
1000 IU/L, protein level above 30 gm/L and WBC over 15,000 cells/mm3.
Exclusion criteria for a primary VATS approach were:
1. Other causes of empyema (other than postpneumonic empyema).
2. An assumed stage III empyema with signs of lung restriction on CT scan.
3. Suspicion of bronchopleural fistula, lung abscess, or tumor.
2.2. Data collection
All patients were studied for the following variables: age, sex, associated comorbidities (diabetes mellitus, hy-
pertension, liver and kidney diseases), duration between onset of symptoms and surgery, laboratory analysis of pleural
fluid (pH, LDH, protein, glucose and involved bacteria), and pleural thickness measured by CT scan.
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Using SPSS 22, summaries of continuous variables were given as mean ± standard deviation, whereas summaries
of binary variables were given as counts and percentages. To determine the predictors for conversion to thoracotomy in
an assumed stage II postpneumonic empyema, many factors were studied such as age, sex, associated comorbidities
(diabetes mellitus, hypertension, liver and kidney diseases), duration between onset of symptoms and surgery, lab-
oratory analysis of pleural fluid (pH, LDH, protein, glucose and involved microorganisms), and pleural thickness
measured by CT scan. Univariate and then multivariate analysis with a multiple logistic regression model were used.
Significance was accepted at p less than 0.05.
3. Results
Between 2011 and 2016, 120 patients underwent surgery for an assumed stage II pleural empyema. All patients had
been initially treated with antibiotics. There were 87 men and 33 women, with a mean age of 45.7 years (range, 20e67
years).
3.1. Surgical procedure
120 patients with an assumed stage II postpneumonic empyema according to the American Thoracic Society
underwent VATS decortications. 38 patients (32%) had been converted to open decortications because of chronicity of
disease (thick pus, thickened pleura or multiple adhesions). VATS decortication without conversion to thoracotomy
was achieved in 82 patients (68%).
3.2. Microbiological evaluation
Bacteriological assessment of the samples obtained during surgery revealed no growth in 29 patients (24.1%).
Previous culture results obtained from samples taken by thoracocentesis before operation were considered to be the
causative microorganisms in 66 patients. Gram negative microorganisms were found in 56% of all patients (in 37
patients with VATS only, and in 30 patients with thoracotomy). Infection caused by Gram-negative microorganisms
was mainly by Haemophilus influenzae, Escherichia coli, Pseudomonas aeruginosa. Infection with Gram-positive
microorganisms was found in 46.6% of all patients (in 45 patients with VATS only, and in 11 patients with thora-
cotomy). Infections caused by Gram-positive microorganisms were mainly by Streptococcus pneumoniae and
Staphylococcus aureus. Anaerobic microorganisms were not detected in this study.
3.3. Predictors for conversion to thoracotomy in the 120 patients with an assumed stage II postpneumonic empyema
Univariate analysis showed that conversion to thoracotomy was higher in patients with long duration between onset
of symptoms and surgery (p < 0.001) with cutoff value at 18.1 days (86% sensitivity and 87% specificity), increased
pleural thickness in CT scan (p < 0.001) with cutoff value at 3.95 mm of pleural thickness (100% sensitivity and 76%
specificity), LDH (p< 0.001) with cutoff value at 1854 IU/L (93% sensitivity and 84% specificity) and the presence of
Gram-negative bacteria in the pleural fluid (p< 0.001). The time duration between onset of symptoms and surgery was
17.27 ± 1.9 days for the patients who underwent thoracoscopic decortication in comparison with 22.31 ± 2.49 days in
the patients with conversion to thoracotomy (Tables 1 and 2).
Multivariate analysis using a stepwise logistic regression model identified the duration between onset of symptoms
and surgery (p < 0.001), Gram-negative bacteria (p ¼ 0.001), LDH (p ¼ 0.003) and pleural thickness (p ¼ 0.012) as
the significant predictors for conversion from VATS to thoracotomy in an assumed stage II postpneumonic empyema,
whereas age, sex, associated comorbidities (diabetes mellitus, hypertension, liver and kidney diseases) pleural pH,
protein and glucose were not (Table 3).
There was a significant correlation between pleural thickness and duration between onset of symptoms and surgery
(p < 0.001) with correlation coefficient ¼ 0.601. There was a significant correlation between gram negative bacteria
and duration between onset of symptoms and surgery (p ¼ 0.022) with correlation coefficient ¼ 0.327. There was a
significant correlation between LDH and time interval between onset of symptoms and surgery (p < 0.001) with
Table 1
Univariate analysis of patients' data.
Variables VATS only n ¼ 82 Conversion to thoracotomy n ¼ 38 p value
Age (mean ± SD) 48.76 ± 10.24 50.1 ± 9.35 0.684
Male/Female n (%) 51/31 (62.1) 23/15 (60.5) 0.477
DM n (%) 29 (35.3) 14 (36.8) 0.623
Hypertension n (%) 27 (32.9) 11 (28.9) 0.887
Liver diseases n (%) 12 (14.6) 8 (21) 0.588
Kidney diseases n (%) 3 (3) 2 (5.2) 0.602
Durationa (mean ± SD) 17.27 ± 1.90 22.31 ± 2.49 <0.001
Leucocytosis Cells/mm3 (mean ± SD) 13.91 ± 2.02 14.25 ± 1.29 0.542
Pleural pH (mean ± SD) 7.05 ± 0.02 7.04 ± 0.04 0.612
Pleural LDH IU/L (mean ± SD) 1174.2 ± 135 1874.6 ± 151 <0.001
Pleural protein gm/L (mean ± SD) 4.53 ± 3.65 4.69 ± 2.75 0.880
Pleural glucose mg/dL (mean ± SD) 27.33 ± 3.36 25.81 ± 4.73 0.685
Pleural thickness in mm (mean ± SD) 2.24 ± 0.70 4.63 ± 0.50 <0.001
Gram positive bacteria n (%) 45 (54.8) 11 (34.3) 0.155
Gram negative bacteria n (%) 37 (45.1) 30 (78.9) <0.001
a Duration between onset of symptoms and surgery in days.
Table 2
Cutoff values using receiver operating characteristic (ROC) curve.
AUCb Cutoff value Sensitivity Specificity
Durationa 0.953 18.1 86% 87%
Pleural thickness (mm) 0.932 3.95 100% 76%
LDH (IU/L) 0.986 1854 93% 84%
AUC > 0.9 ¼ excellent test results.
a Duration between onset of symptoms and surgery in days.
b Area under the curve. AUC > 0.9 ¼ excellent test results.
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with correlation coefficient ¼ 0.627 (Table 4).
3.4. Mortality and morbidity
There was no mortality in the first 30 days postoperatively. There was no significant difference between patients
with VATS only and patients with thoracotomy regarding postoperative complications.
4. Discussion
This study was designed to determine the predictors for conversion to thoracotomy in patients undergoing VATS
for an assumed stage II postpneumonic empyema by using a multivariate analysis in 120 patients. These predictorsTable 3
Multivariate analysis with a multiple stepwise logistic regression.
Variable Unstandardized
coefficients B
95.0% confidence interval
for B (lower bound)
95.0% confidence interval
for B (upper bound)
Standardized
coefficients beta
Sig.
Durationa 0.037 0.014 0.061 0.550 0.000
Gram-negative bacteria 0.201 0.088 0.315 0.214 0.001
LDH 0.054 0.011 0.078 0.230 003.0
Pleural thickness in mm 0.106 0.024 0.187 0.204 0.012
a Duration between onset of symptoms and surgery in days.
Table 4
Bivariate correlations analysis.
Durationa Pleural thickness in mm Gram- negative bacteria LDH
Durationa Pearson correlation 1 0.601b 0.327c 0.583b
Sig. 0.000 0.022 0.000
Pleural thickness in mm Pearson correlation 0.601b 1 0.136 0.627b
Sig. 0.000 0.352 0.000
Gram-negative bacteria Pearson correlation 0.327c 0.136 1 0.131
Sig. 0.022 0.352 0.370
LDH Pearson correlation 0.583b 0.627b 0.131 1
Sig. 0.000 0.000 0.370
a Duration between onset of symptoms and surgery in days.
b Correlation is significant at the 0.01 level.
c Correlation is significant at the 0.05 level.
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pleural thickness.
Of the 120 patients, conversion to thoracotomy was indicated only in 38 (32%) patients due to chronicity of the
disease. VATS decortication was successful in 82 (68%) of our all patients. These results are better than the results
obtained from earlier report in which 38% of the patients with empyema were managed by VATS and 62% by open
decortication [15].
Many reports have discussed the effect of increased duration between onset of symptoms and surgery on the
chronicity of empyema and on the possibility of a successful treatment by VATS [10,14,16e19]. VATS decortication
can be performed successfully when the duration between onset of symptoms and surgery is between 1 and 2 weeks.
This is because patients with stage III disease usually have a long duration between onset of symptoms and surgery
(>3 weeks) and usually present with a thickened enhanced pleura with signs of restriction on CT scan [19]. The
duration between onset of symptoms and surgery was the most important predictor for conversion to thoracotomy in a
multivariate analysis performed for this purpose. The rate of conversion from VATS to thoracotomy in patients with
postpneumonic empyema has been analyzed in many reports and it was ranging from 18% to 59% [10,18,20e22].
This discrepancy may be explained by the different timing of referral for surgery between the reported series and the
different policies of medical treatment before surgery.
The second predictor for conversion to thoracotomy in patients with an assumed stage II empyema was the
presence of Gram-negative bacteria in pleural fluid which were associated with an increased incidence of conversion
to thoracotomy. It has been suggested that the type and virulence of the involved bacteria affect the rapidity of
progression and stage transition of empyema [22].
The third predictor for conversion to thoracotomy in patients with assumed stage II empyema was LDH. Lactate
dehydrogenase is released during tissue damage. So, it is used as a marker of common injuries and disease. In em-
pyema, the LDH levels will exceed 1000 IU/L [13]. In this study, LDH > 1854 IU/L was found to be a cutoff value for
conversion to thoracotomy (93% sensitivity and 84% specificity). Furthermore, there was a significant correlation
between LDH and duration between onset of symptoms and surgery (p < 0.001) with correlation coefficient ¼ 0.583.
In addition, there was a significant correlation between LDH and pleural thickness (p < 0.001) with correlation
coefficient ¼ 0.627.
The fourth predictor for conversion to thoracotomy in patients with an assumed stage II empyema was the pleural
thickness. It can be assessed by Computer Tomography imaging (CT scan) which also detects pleural enhancement
and encysted effusion. The presence of pleural thickening and signs of lung restriction on CT scan refers to stage III
empyema [3] which was one of the exclusion criteria in our series. In this study, the cutoff value for conversion to
thoracotomy was 3.95 mm of pleural thickness (100% sensitivity and 76% specificity). There was a significant
correlation between pleural thickness and duration between onset of symptoms and surgery (p < 0.001) with cor-
relation coefficient ¼ 0.601. Furthermore, there was a significant correlation between LDH and pleural thickness
(p < 0.001) with correlation coefficient ¼ 0.627.
The relative small number of patients and the absence of pediatric age group were the most important limitations of
this study.
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version to thoracotomy should be applied. These predictors included long duration between onset of symptoms and
surgery (>18 days), the presence of Gram-negative bacteria, LDH > 1854 IU/L, and pleural thickness >3.95 mm.
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